Dermata Therapeutics Ownership | Who Owns Dermata Therapeutics?


OverviewForecastFinancialsChart

Dermata Therapeutics Ownership Summary


Dermata Therapeutics is owned by 38.16% institutional investors, and 61.84% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.44% of its assets in Dermata Therapeutics shares.

DRMA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockDermata Therapeutics38.16%-61.84%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20221122.22%292,76248.44%385.77%740.00%1-
Sep 30, 20229-10.00%197,232-76.89%250.17%5-37.50%1-
Jun 30, 20221042.86%853,4491074.14%12162.91%8100.00%--100.00%
Mar 31, 20227-30.00%72,687-44.17%130.59%4-55.56%1-
Dec 31, 20211025.00%130,204-50.67%480.50%928.57%1-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Extended Market Index6.71K0.44%1.86K
Fidelity Nasdaq Composite Index66.000.00%-
SSgA U.S. Extended Market Index Class I68.000.00%-
State St US Extended Mkt Indx NL Cl C4.000.00%-
SSgA U.S. Total Market Index Strategy2.000.00%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 23, 2021PROEHL GERALD T President, CEO and ChairmanBuy$48.00K
Aug 17, 2021HALE DAVID F-Buy$250.00K
Aug 16, 2021PROEHL GERALD T President, CEO and ChairmanBuy$1000.00K
Aug 16, 2021PROEHL GERALD T President, CEO and ChairmanBuy$1000.00K
Aug 16, 2021PROEHL GERALD T President, CEO and ChairmanBuy$49.63K

Insider Transactions Trends


DateBuySell
2024 Q1--
2023 Q1--
2022 Q4--
2022 Q3--
2022 Q2--

DRMA Ownership FAQ


Who Owns Dermata Therapeutics?

Dermata Therapeutics shareholders are primarily institutional investors at 38.16%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Dermata Therapeutics's industry, Biotech Stocks , is 47.04%, which Dermata Therapeutics falls below.

Does Blackrock own Dermata Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Dermata Therapeutics.

Who is the top mutual fund holder of Dermata Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Dermata Therapeutics shares, with 0.44% of its total shares outstanding invested in 6.71K Dermata Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools